US 8119827
Compounds for treatment of cell proliferative diseases
granted A61KA61K31/277A61K45/06
Quick answer
US patent 8119827 (Compounds for treatment of cell proliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/277, A61K45/06, A61P, A61P1/00